- Home
- RAIL vs BDTX Comparison
RAIL vs BDTX Comparison
Compare RAIL & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAIL
- BDTX
- Stock Information
- Founded
- RAIL 1901
- BDTX 2014
- Country
- RAIL United States
- BDTX United States
- Employees
- RAIL N/A
- BDTX N/A
- Industry
- RAIL Railroads
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RAIL Industrials
- BDTX Health Care
- Exchange
- RAIL Nasdaq
- BDTX Nasdaq
- Market Cap
- RAIL 155.7M
- BDTX 132.5M
- IPO Year
- RAIL N/A
- BDTX 2020
- Fundamental
- Price
- RAIL $8.74
- BDTX $2.51
- Analyst Decision
- RAIL
- BDTX Strong Buy
- Analyst Count
- RAIL 0
- BDTX 6
- Target Price
- RAIL N/A
- BDTX $14.83
- AVG Volume (30 Days)
- RAIL 136.4K
- BDTX 1.4M
- Earning Date
- RAIL 08-11-2025
- BDTX 08-05-2025
- Dividend Yield
- RAIL N/A
- BDTX N/A
- EPS Growth
- RAIL N/A
- BDTX N/A
- EPS
- RAIL N/A
- BDTX 0.09
- Revenue
- RAIL $494,657,000.00
- BDTX $70,000,000.00
- Revenue This Year
- RAIL $3.13
- BDTX N/A
- Revenue Next Year
- RAIL $5.86
- BDTX N/A
- P/E Ratio
- RAIL N/A
- BDTX $28.38
- Revenue Growth
- RAIL 12.90
- BDTX N/A
- 52 Week Low
- RAIL $3.02
- BDTX $1.20
- 52 Week High
- RAIL $16.10
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- RAIL 58.53
- BDTX 58.48
- Support Level
- RAIL $8.52
- BDTX $2.34
- Resistance Level
- RAIL $8.97
- BDTX $2.62
- Average True Range (ATR)
- RAIL 0.37
- BDTX 0.17
- MACD
- RAIL -0.06
- BDTX -0.01
- Stochastic Oscillator
- RAIL 57.14
- BDTX 63.39
About RAIL FreightCar America Inc.
FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.